UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice

Blood, 2012-03, Vol.119 (13), p.3164-3175

2012

Volltextzugriff (PDF)

Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation

PloS one, 2011-11, Vol.6 (11), p.e25911

2011

Volltextzugriff (PDF)

The development of combretastatin A4 phosphate as a vascular targeting agent

International journal of radiation oncology, biology, physics, 2002-12, Vol.54 (5), p.1491-1496

2002

Volltextzugriff (PDF)

Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform-Producing Tumors

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2301-2311

2008

Volltextzugriff (PDF)

Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses

Clinical cancer research, 2009-06, Vol.15 (11), p.3781-3790

2009

Volltextzugriff (PDF)

VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice

Blood, 2013-04, Vol.121 (16), p.3289-3297

2013

Volltextzugriff (PDF)

The quest for epic: from Ariosto to Tasso

The quest for epic, 2006

1, 2006

Volltextzugriff (PDF)

Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect

Oncotarget, 2016-11, Vol.7 (47), p.76613-76627

2016

Volltextzugriff (PDF)

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy

Advanced drug delivery reviews, 2005-01, Vol.57 (1), p.135-152

2005

Volltextzugriff (PDF)

Vascular effects dominate solid tumor response to treatment with combretastatin A‐4‐phosphate

International journal of cancer, 2011-10, Vol.129 (8), p.1979-1989

2011

Volltextzugriff (PDF)

The biology of the combretastatins as tumour vascular targeting agents

International journal of experimental pathology, 2002-02, Vol.83 (1), p.21-38

2002

Volltextzugriff (PDF)

ZD6126: A novel vascular-targeting agent that causes selective destruction of tumor vasculature

Cancer research (Chicago, Ill.), 2002-12, Vol.62 (24), p.7247-7253

2002

Volltextzugriff (PDF)

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

Cancer research (Chicago, Ill.), 1997-05, Vol.57 (10), p.1829-1834

1997

Volltextzugriff (PDF)

Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (12), p.4716-4722

2001

Volltextzugriff (PDF)

The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability

Cancer research (Chicago, Ill.), 2001-09, Vol.61 (18), p.6811-6815

2001

Volltextzugriff (PDF)

Preclinical evaluation of the antitumour activity of the novel vascular targeting agent Oxi 4503

Anticancer research, 2002-05, Vol.22 (3), p.1453

2002

Volltextzugriff (PDF)

Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS

NMR in biomedicine, 2002-04, Vol.15 (2), p.99-105

2002

Volltextzugriff (PDF)

Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models

International journal of cancer, 2002-11, Vol.102 (1), p.70-74

2002

Volltextzugriff (PDF)

Synergy between vascular targeting agents and antibody-directed therapy

International journal of radiation oncology, biology, physics, 2002-12, Vol.54 (5), p.1524-1531

2002

Volltextzugriff (PDF)

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations

Radiotherapy and oncology, 1999-02, Vol.50 (2), p.167-171

1999

Volltextzugriff (PDF)

Enhancement of vascular targeting by inhibitors of nitric oxide synthase

International journal of radiation oncology, biology, physics, 2002-12, Vol.54 (5), p.1532-1536

2002

Volltextzugriff (PDF)

Tumour radiosensitization by high-oxygen-content gases : Influence of the carbon dioxide content of the inspired gas on PO2, microcirculatory function and radiosensitivity

International journal of radiation oncology, biology, physics, 1998-03, Vol.40 (4), p.943-951

1998

Volltextzugriff (PDF)

Ischemia reperfusion injury in tumors : the role of oxygen radicals and nitric oxide

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (24), p.6026-6029

1995

Volltextzugriff (PDF)

Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation

International journal of radiation oncology, biology, physics, 1994-06, Vol.29 (3), p.439-442

1994

Volltextzugriff (PDF)

Human tumor blood flow is enhanced by nicotinamide and carbogen breathing

Cancer research (Chicago, Ill.), 1997-12, Vol.57 (23), p.5261-5264

1997

Volltextzugriff (PDF)

1 – 25 von 667

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(561)
Mit Volltextzugriff
(538)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(664)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice

Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation

The development of combretastatin A4 phosphate as a vascular targeting agent

Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform-Producing Tumors

Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses

VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice

The quest for epic: from Ariosto to Tasso

Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy

Vascular effects dominate solid tumor response to treatment with combretastatin A‐4‐phosphate

The biology of the combretastatins as tumour vascular targeting agents

ZD6126: A novel vascular-targeting agent that causes selective destruction of tumor vasculature

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate

The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability

Preclinical evaluation of the antitumour activity of the novel vascular targeting agent Oxi 4503

Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS

Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models

Synergy between vascular targeting agents and antibody-directed therapy

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations

Enhancement of vascular targeting by inhibitors of nitric oxide synthase

Tumour radiosensitization by high-oxygen-content gases : Influence of the carbon dioxide content of the inspired gas on PO2, microcirculatory function and radiosensitivity

Ischemia reperfusion injury in tumors : the role of oxygen radicals and nitric oxide

Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation

Human tumor blood flow is enhanced by nicotinamide and carbogen breathing

Suchergebnisse filtern